Q3 2024 Holdings
Filed 2024-11-13 | 58 holdings | $334.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $33.3M | 1,731,191 | 10.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $32.0M | 2,769,819 | 9.6% |
| Merus N V | COM | N5749R100 | $21.0M | 421,222 | 6.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $19.1M | 671,001 | 5.7% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $16.5M | 1,778,318 | 5.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $15.8M | 1,481,809 | 4.7% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $14.2M | 275,303 | 4.3% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $13.2M | 1,554,586 | 4.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $10.9M | 213,815 | 3.3% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $10.8M | 216,440 | 3.2% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $10.0M | 174,034 | 3.0% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $9.5M | 2,616,602 | 2.8% |
| Incyte Corp(INCY) | COM | 45337C102 | $8.6M | 129,490 | 2.6% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $8.2M | 282,050 | 2.5% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $7.1M | 506,978 | 2.1% |
| Acelyrin Inc | COM | 00445A100 | $6.5M | 1,317,854 | 1.9% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $6.2M | 123,177 | 1.9% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $6.0M | 1,278,444 | 1.8% |
| Immatics N.v(IMTX) | SHS | N44445109 | $5.1M | 449,735 | 1.5% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $5.0M | 86,930 | 1.5% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $5.0M | 60,076 | 1.5% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $4.9M | 1,846,792 | 1.5% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $4.6M | 203,015 | 1.4% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $4.3M | 860,951 | 1.3% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $4.2M | 1,044,168 | 1.3% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $4.2M | 132,703 | 1.3% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $3.7M | 449,321 | 1.1% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $3.2M | 238,084 | 1.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $3.1M | 850,210 | 0.9% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $3.1M | 73,299 | 0.9% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $3.1M | 241,984 | 0.9% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $2.5M | 743,719 | 0.8% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $2.5M | 300,000 | 0.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $2.4M | 94,885 | 0.7% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $2.2M | 49,415 | 0.7% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $2.2M | 182,918 | 0.7% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $2.2M | 41,268 | 0.6% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $2.1M | 200,000 | 0.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $1.9M | 15,014 | 0.6% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $1.7M | 942,857 | 0.5% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $1.5M | 150,000 | 0.5% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $1.4M | 55,523 | 0.4% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $1.4M | 93,638 | 0.4% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.4M | 48,918 | 0.4% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $1.3M | 83,662 | 0.4% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $1.3M | 50,000 | 0.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $763.7K | 14,464 | 0.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $755.3K | 16,654 | 0.2% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $618.9K | 56,287 | 0.2% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $531.1K | 19,900 | 0.2% |